Atherosclerosis

heart valentines day valentine puzzle merger MA
Research

Repair licenses Genevant's tech for up to $107M per product

Repair will use Genevant's lipid nanoparticle technology to create cholesterol-degrading treatments for atherosclerosis.
Darren Incorvaia Sep 26, 2024 2:53pm
heart coronary artery cardiovascular scan MRI

Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol

May 29, 2024 11:00am
arrow target quiver aim shoot ammo

Arrowhead's cholesterol drug hits the mark again in ph. 2 trial

May 28, 2024 9:13am
An artists depiction of a heart with a clogged artery

AstraZeneca drug once tested for cancer slows atherosclerosis

Jun 9, 2023 7:40am
uproot tree

Bitterroot Bio emerges from stealth with $145M series A

Jun 7, 2023 8:00am
An artists rendition of plaque buildup in an artery The plaque is a yellow fatty substance that is nearly blocking off red

Scientists pinpoint location of plaque ruptures

Jun 6, 2023 7:35am